CLINICAL_TRIALS
trial_result
· 2019-02-08
Clinical Trial Update: Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01) [Phase 4]
Summary
Phase 4 follow-up study of fingolimod in relapsing-remitting multiple sclerosis; results from the original biobank study were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2019-02-08